MESENCHYMAL STEM CELLS: A REGENERATIVE HOPE FOR ALZHEIMER'S PATIENTS

Authors

  • Rehab H Abdel-Aziz, Omyma Galal Ahmed, Abeer Madkour Mahmoud, Hanan H Abd-Elhafeez, Lamiaa Abd-Elsamiee, Rana Toghan

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory impairment, and neuronal loss. Despite extensive research, effective disease-modifying therapies remain limited. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic candidate due to their multipotent properties, immunomodulatory capacity, and ability to secrete neurotrophic factors. This review explores various aspects of AD, as well as it explores MSCs mechanisms of action including reduction of neuroinflammation, promotion of neurogenesis, clearance of amyloid-β plaques, and protection against oxidative stress. We also discuss the various sources of MSCs, and methods of delivery.

Downloads

Published

2025-04-20

How to Cite

Rehab H Abdel-Aziz, Omyma Galal Ahmed, Abeer Madkour Mahmoud, Hanan H Abd-Elhafeez, Lamiaa Abd-Elsamiee, Rana Toghan. (2025). MESENCHYMAL STEM CELLS: A REGENERATIVE HOPE FOR ALZHEIMER’S PATIENTS. Chelonian Research Foundation, 139–150. Retrieved from http://acgpublishing.com/index.php/CCB/article/view/882

Issue

Section

Articles